|
RAS mutations concordance in circulating tumor DNA (ctDNA) and tissue in metastatic colorectal cancer (mCRC): RASANC, an AGEO prospective multicenter study. |
|
|
|
Honoraria - Amgen; Celgene; Merck Serono; Roche; Sanofi |
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; SERVIER |
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche |
|
|
Consulting or Advisory Role - Amgen; Lilly; Merck Serono; Novartis; Roche |
|
|
Honoraria - Amgen; Baxalta; Celgene; Lilly; Merck; Roche |
Consulting or Advisory Role - Amgen; Baxalta; Celgene; Lilly; Merck; Roche |
Travel, Accommodations, Expenses - Celgene; Merck; Roche |
|
|
Consulting or Advisory Role - Ipsen; Lilly; Merck Serono; Novartis; Sanofi |
Travel, Accommodations, Expenses - Celgene; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Novartis |
Travel, Accommodations, Expenses - Novartis |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Sanofi |
Travel, Accommodations, Expenses - Amgen; Ipsen; Sanofi |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Honoraria - Boehringer Ingelheim; Raindance Technologies |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Celgene; IntegraGen; IntegraGen; Ipsen; Janssen; Merck Serono; Merck Serono; Nestle health science; Novartis; Roche |
|
|
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Lilly; Roche |